Quick to pick up on that.Announcement out at 8.46 this morningWe have been included in the ASX 300.Lots more research and exposure now. $150 gone and dusted. Bring on $2.00.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%